16 Oct
2025
15:00 E.S.T.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

Read more

16 Oct
2025
07:00 E.S.T.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

Read more

07 Oct
2025
02:40 E.S.T.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Read more

04 Aug
2025
16:30 E.S.T.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Read more

28 Jul
2025
16:30 E.S.T.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

Read more

26 Jun
2025
16:30 E.S.T.

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Read more

21 May
2025
16:30 E.S.T.

Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025

Read more

12 May
2025
16:30 E.S.T.

Cellectis Reports Financial Results for the First Quarter 2025

Read more

06 May
2025
16:30 E.S.T.

Cellectis to Report First Quarter Financial Results on May 12, 2025

Read more

28 Apr
2025
16:30 E.S.T.

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Read more